Section 1
Enlarged prostate sufferers have historically had to choose between maintenance medications that may not adequately treat BPH symptoms and invasive surgical procedures that may carry a high risk of undesirable side effects.
Cleared to treat prostates up to 100cc, the UroLift® System is a minimally invasive procedure that can be an effective early treatment option for BPH. With no cutting, heating or removal of prostate tissue, the UroLift System provides immediate, visible results and rapid symptom relief, with recovery in days, not months.5,6, 20
UroLift may be the right treatment option for men seeking a solution that:
UroLift-trained urologists in your area can assess if the UroLift System is right for your patient.
A recent study in the Journal of Urology showed an association with alpha-blockers and 5-alpha reductase inhibitors and new reports of heart failure. Read more about the study in this Urology Times article.
Section 1
The UroLift System uses a proven approach to treating BPH that lifts and holds the enlarged prostate tissue out of the way, so it no longer blocks the urethra. It is the only leading transurethral BPH treatment that does not require heating, cutting or removal of the prostate tissue. Post-procedure, most patients do not require ongoing BPH medications.6
Click through the steps below to see how the UroLift System simply reopens the channel.
Go to step 1 >The UroLift® Delivery Device is placed through the obstructed urethra to access the enlarged prostate.
Go to step 2 >Small UroLift implants are permanently placed to lift and hold the enlarged prostate tissue out of the way and increase the opening of the urethra.
Go to step 3 >The UroLift Delivery Device is removed, leaving an open urethra designed to provide symptom relief.
Section 2
Quality of life and overall health are important considerations in treating men with BPH. Watchful waiting can risk bladder health.3 Medications can cause bothersome side effects and often fail to provide significant symptom relief.2
Section 3
The UroLift System is indicated for the treatment of symptoms of an enlarged prostate up to 100cc in men 45 years or older (50 or older outside the U.S.). Consider referring your eligible** patients with BPH to a UroLift-trained urologist if they meet these indications and who:
This brochure provides information about BPH and the UroLift System. Please feel free to share it with your BPH patients. Patient information is also available online at: urolift.com/patient-resources.
Clinical results from over 28 peer-reviewed publications demonstrate that treatment with the UroLift System offers rapid and significant improvements in symptoms, urinary flow and quality of life with lasting relief.6
Source Information
1. Roehrborn, J Urol 2013
2. AUA Guidelines 2003, 2020
3. Tubaro, Drugs Aging 2003
4. Sonksen, Eur Urol 2015
5. Shore, Can J Urol 2014
6. Roehrborn, Can J Urol 2017
7. Mirone, Eur Urol 2007; 51: 57-66
8. Djavan, Urology 2004; 64: 1144-1148
9. Flanigan, J Urol 1998
10. Wei, et al, J Urol April 2010 abstract
11. Pearson, Am Fam Physician 2014
12. Cindolo, Eur Urol Sep 2015
*No instances of new, sustained erectile or ejaculatory dysfunction in the L.I.F.T. pivotal study
**Contraindicated in men with current gross hematuria, urinary tract infection, urinary incontinence, urethral conditions that prevent device insertion, or a prostate volume greater than 100cc.
†Individual results may vary. See complete safety information at UroLift.com/Patient-Safety.
MAC02179-01 Rev A
© 2023 All rights reserved. | Terms of Use | Privacy Policy | Patient Safety